Clinical Trial Update: Tobramycin Injection to Prevent Infection in Open Fractures [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Tobramycin Injection to prevent infection in patients with open fractures, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open Fracture
• Surgical Site Infection
• Wound Infection

Drugs mentioned

• Tobramycin Injection (tobramycin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Wound Infection, Fractures, Open | Phase 3 | Status: ACTIVE_NOT_RECRUITING